Effect of a coronary vasodilating substance, carbocromen, on the coronary blood flow under hypoxia and administration of adrenergic blocking agents.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D003326:Coronary Circulation / Q000187:drug effects*; D003331:Coronary Vessels / Q000187:drug effects; D003374:Coumarins / Q000494:pharmacology*; D004285:Dogs; D004566:Electrodes; D005021:Ethylamines / Q000378:metabolism; D006016:Glycolates / Q000378:metabolism; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D000860:Hypoxia; D008297:Male; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012121:Respiration, Artificial; D014665:Vasodilator Agents / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D003374:Coumarins; D005021:Ethylamines; D006016:Glycolates; D014665:Vasodilator Agents; D011433:Propranolol; D010100:Oxygen; D010646:Phentolamine